cp 122288 has been researched along with Inflammation in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brown, D; Butler, P; Ellis, P; Grayson, KL; Gupta, P; Land, GC; Macor, JE; Robson, SF; Shepperson, NB; Wythes, MJ | 1 |
| Johnson, KW; Phebus, LA | 1 |
2 other study(ies) available for cp 122288 and Inflammation
| Article | Year |
|---|---|
The in vivo pharmacological profile of a 5-HT1 receptor agonist, CP-122,288, a selective inhibitor of neurogenic inflammation.
Topics: Anesthesia; Animals; Anti-Inflammatory Agents, Non-Steroidal; Capillary Permeability; Dogs; Dose-Response Relationship, Drug; Dura Mater; Electric Stimulation; Hemodynamics; Inflammation; Male; Pyrrolidines; Rats; Rats, Sprague-Dawley; Serotonin Receptor Agonists; Species Specificity; Sumatriptan; Trigeminal Ganglion; Vasoconstriction | 1995 |
A fluorescence-based method for assessing dural protein extravasation induced by trigeminal ganglion stimulation.
Topics: Animals; Biological Transport; Dura Mater; Electric Stimulation; Evans Blue; Extravasation of Diagnostic and Therapeutic Materials; Fluorescence; Guinea Pigs; Inflammation; Injections, Intravenous; Male; Microscopy, Fluorescence; Microspectrophotometry; Migraine Disorders; Protein Binding; Proteins; Pyrrolidines; Sumatriptan; Trigeminal Ganglion | 1998 |